REGENXBIO (NASDAQ:RGNX) Upgraded at StockNews.com
REGENXBIO (NASDAQ:RGNX – Get Free Report) was upgraded by research analysts at StockNews.com from a “sell” rating to a “hold” rating in a research report issued on Friday. Several other equities research analysts also recently issued reports on the stock. Chardan Capital reiterated a “buy” rating and set a $52.00 price objective on shares of […]
REGENXBIO (NASDAQ:RGNX – Get Free Report) was upgraded by research analysts at StockNews.com from a “sell” rating to a “hold” rating in a research report issued on Friday. Several other equities research analysts also recently issued reports on the stock. Chardan Capital reiterated a “buy” rating and set a $52.00 price objective on shares of […]
